Passage Bio Ownership | Who Owns Passage Bio?


OverviewForecastRevenueFinancialsChart

Passage Bio Ownership Summary


Passage Bio is owned by 62.61% institutional investors, 0.49% insiders, and 36.91% retail investors. Orbimed advisors is the largest institutional shareholder, holding 17.98% of PASG shares. Worldwide Healthcare Ord is the top mutual fund, with 3.38% of its assets in Passage Bio shares.

PASG Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockPassage Bio62.61%0.49%36.91%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Orbimed advisors10.12M17.98%$8.04M
Vestal point capital, lp6.05M10.75%$4.81M
Lynx1 capital management lp5.06M8.98%$4.02M
New leaf venture partners2.50M4.44%$1.98M
Vanguard group2.07M3.68%$1.65M
Tang capital management1.50M2.66%$1.19M
Renaissance1.13M2.00%$893.93K
Acadian asset management961.27K1.71%$762.00K
Blackrock817.53K1.45%$649.28K
Millennium management750.93K1.33%$596.38K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
New leaf venture partners2.50M2.41%$1.98M
Vestal point capital, lp6.05M0.36%$4.81M
Lynx1 capital management lp5.06M0.26%$4.02M
Orbimed advisors10.12M0.16%$8.04M
Tang capital management1.50M0.12%$1.19M
Dlk investment management64.00K0.02%$50.83K
Bridgeway capital management556.14K0.01%$441.69K
Rbf capital142.81K0.01%$113.42K
Fiduciary trust215.00K0.00%$170.75K
Acadian asset management961.27K0.00%$762.00K

Top Buyers

HolderShares% AssetsChange
Vestal point capital, lp6.05M0.36%1.55M
Lynx1 capital management lp5.06M0.26%211.76K
Geode capital management431.11K-46.83K
Tower research capital llc (trc)13.20K0.00%13.17K
Ubs group1.15K-1.15K

Top Sellers

HolderShares% AssetsChange
Versant venture management---4.03M
Acuitas investments---471.81K
Affinity asset advisors---264.27K
Two sigma advisers, lp---209.60K
Pale fire capital se---141.44K

New Positions

HolderShares% AssetsChangeValue
Harbour investments60.00-60.00$48.00

Sold Out

HolderChange
Qube research-4.00
Federation des caisses desjardins du quebec-10.00
Advisor group-217.00
Wells fargo & company/mn-309.00
Global retirement partners-400.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202444-38,667,1522.24%621.39%1972.73%7-36.36%
Jun 30, 202444-12.00%37,821,661-0.07%671.42%11-45.00%11-15.38%
Mar 31, 202450-37,847,26127.02%682.33%20-4.76%1330.00%
Dec 31, 2023502.04%29,797,319-0.77%541.80%2140.00%10-23.08%
Sep 30, 202349-9.26%30,028,681-3.78%541.68%15-6.25%13-27.78%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Worldwide Healthcare Ord2.09M3.38%-
Vanguard Total Stock Mkt Idx Inv1.50M2.42%-
Vanguard Institutional Extnd Mkt Idx Tr493.23K0.80%-
Bridgeway Ultra-Small Company416.04K0.67%-
Galileo - Biotech Innovation Fund S USD412.28K0.67%-
Fidelity Extended Market Index300.98K0.49%42.73K
Bridgeway Ultra-Small Company Market140.10K0.23%-
iShares Micro-Cap ETF128.72K0.21%-
BlackRock Extended Equity Market K75.13K0.12%-32.00
Fidelity Series Total Market Index69.59K0.11%25.46K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 11, 2024ORBIMED ADVISORS LLC-Sell$64.00
Dec 10, 2024ORBIMED ADVISORS LLC-Sell$6.41K
Dec 09, 2024ORBIMED ADVISORS LLC-Sell$45.51K
Dec 06, 2024ORBIMED ADVISORS LLC-Sell$17.14K
Dec 04, 2024ORBIMED ADVISORS LLC-Sell$60.20K

Insider Transactions Trends


DateBuySell
2024 Q435
2024 Q3-4
2024 Q2--
2024 Q1-5
2023 Q4--

PASG Ownership FAQ


Who Owns Passage Bio?

Passage Bio shareholders are primarily institutional investors at 62.61%, followed by 0.49% insiders and 36.90% retail investors. The average institutional ownership in Passage Bio's industry, Biotech Stocks , is 47.04%, which Passage Bio exceeds.

Who owns the most shares of Passage Bio?

Passage Bio’s largest shareholders are Orbimed advisors (10.12M shares, 17.98%), Vestal point capital, lp (6.05M shares, 10.75%), and Lynx1 capital management lp (5.06M shares, 8.98%). Together, they hold 37.72% of Passage Bio’s total shares outstanding.

Does Blackrock own Passage Bio?

Yes, BlackRock owns 1.45% of Passage Bio, totaling 817.53K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 649.28K$. In the last quarter, BlackRock decreased its holdings by -105K shares, a -11.38% change.

Who is Passage Bio’s biggest shareholder by percentage of total assets invested?

New leaf venture partners is Passage Bio’s biggest shareholder by percentage of total assets invested, with 2.41% of its assets in 2.5M Passage Bio shares, valued at 1.98M$.

Who is the top mutual fund holder of Passage Bio shares?

Worldwide Healthcare Ord is the top mutual fund holder of Passage Bio shares, with 3.38% of its total shares outstanding invested in 2.09M Passage Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools